In an exclusive Genomic Press Interview, Dr. Romina Mizrahi discusses how PET imaging allows scientists to explore the ...

BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.

Insoluble tau aggregates, particularly neurofibrillary tangles, play a crucial role in the pathology of Alzheimer’s disease. These aggregates correlate closely with the clinical symptoms of the ...

advancements in diagnostic testing modalities have supported the detection of AD pathology in living patients using positron emission tomography (PET), cerebrospinal fluid (CSF) biomarkers and ...

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

Labcorp (LH) announced the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based biomarker test to aid in the ...

Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron’s innovative PET/PET-CT technologies, clinical ...